We are live on ! Find out more
FSA

Fort Sheridan Advisors Portfolio holdings

AUM $828M
1-Year Est. Return 26.67%
This Fund
S&P 500
This Quarter Est. Return
-6.08%
1 Year Est. Return
+26.67%
3 Year Est. Return
+87.15%
5 Year Est. Return
+109.16%
10 Year Est. Return
AUM
$297M
AUM Growth
-$10.9M
Cap. Flow
+$12.1M
Cap. Flow %
4.07%
Top 10 Hldgs %
48.29%
Holding
194
New
9
Increased
82
Reduced
29
Closed
10

Top Sells

Rank Stock Value
1
MRVL icon
Marvell Technology
MRVL
+$986K
2
COHR
Coherent Inc
COHR
+$409K
3
VTR icon
Ventas
VTR
+$254K
4
KMB icon
Kimberly-Clark
KMB
+$230K
5
CTVA icon
Corteva
CTVA
+$215K

Sector Composition

Rank Sector Weight
1 Financials 25.07%
2 Technology 23.98%
3 Healthcare 10.45%
4 Energy 9.93%
5 Industrials 5.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPIC
101
DELISTED
TPI Composites
TPIC
$497K 0.17%
44,057
-830
-2% -$13.1K
VYM icon
102
Vanguard High Dividend Yield ETF
VYM
$82.6B
$485K 0.16%
5,110
+51
+1% +$5.3K
WFC icon
103
Wells Fargo
WFC
$267B
$484K 0.16%
12,035
-1,100
-8% -$47.3K
CI icon
104
Cigna
CI
$72.4B
$472K 0.16%
1,702
VTV icon
105
Vanguard Morningstar Value ETF
VTV
$191B
$458K 0.15%
3,705
+174
+5% +$23.5K
GILD icon
106
Gilead Sciences
GILD
$168B
$455K 0.15%
7,376
-2
-0% -$126
LEA icon
107
Lear
LEA
$6.21B
$445K 0.15%
3,718
AMGN icon
108
Amgen
AMGN
$210B
$434K 0.15%
1,926
+41
+2% +$9.94K
C icon
109
Citigroup
C
$230B
$432K 0.15%
10,368
VRTX icon
110
Vertex Pharmaceuticals
VRTX
$121B
$432K 0.15%
1,492
NVS icon
111
Novartis
NVS
$291B
$427K 0.14%
5,622
-25
-0.4% -$2.07K
BMY icon
112
Bristol-Myers Squibb
BMY
$135B
$426K 0.14%
5,991
-167
-3% -$12.1K
H icon
113
Hyatt Hotels
H
$16.4B
$405K 0.14%
5,000
ENVX icon
114
Enovix
ENVX
$960M
$392K 0.13%
24,453
+2,143
+10% +$31.6K
NTLA icon
115
Intellia Therapeutics
NTLA
$1.58B
$387K 0.13%
6,920
CAT icon
116
Caterpillar
CAT
$404B
$385K 0.13%
2,345
KO icon
117
Coca-Cola
KO
$372B
$379K 0.13%
6,762
-138
-2% -$8.58K
WMT icon
118
Walmart Inc
WMT
$888B
$378K 0.13%
8,736
DGRO icon
119
iShares Core Dividend Growth ETF
DGRO
$43.4B
$373K 0.13%
8,384
+566
+7% +$27.9K
SGMO
120
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$363K 0.12%
74,051
-327
-0.4% -$1.68K
NTNX icon
121
Nutanix
NTNX
$16.6B
$352K 0.12%
16,889
-4,549
-21% -$83K
EZU icon
122
iShare MSCI Eurozone ETF
EZU
$9.85B
$344K 0.12%
10,769
XLE icon
123
State Street Energy Select Sector SPDR ETF
XLE
$38.4B
$344K 0.12%
9,550
-600
-6% -$22.7K
IYH icon
124
iShares US Healthcare ETF
IYH
$3.45B
$343K 0.12%
+6,780
New +$366K
SHYG icon
125
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.61B
$335K 0.11%
8,395
+2,001
+31% +$82.7K

Similar funds

Fort Sheridan Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Fort Sheridan Advisors held 194 positions worth $297M, down 3.6% from $308M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Fort Sheridan Advisors deployed $12.1M of net new capital in Q3 2022, opening 9 new positions and adding to 82 existing holdings. Its largest new stake was iShares US Healthcare ETF: 6,780 shares worth $343K.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Visa, an estimated $108K trimmed.

  • Fort Sheridan Advisors's largest Q3 2022 buy was iShares US Healthcare ETF: 6,780 shares worth $343K.
  • Fort Sheridan Advisors added most to Vanguard S&P 500 ETF in Q3 2022, an estimated $874K increase.
  • Fort Sheridan Advisors's biggest Q3 2022 reduction was Visa, cutting an estimated $108K.
  • Fort Sheridan Advisors fully exited Marvell Technology in Q3 2022, selling an estimated $986K.
  • Fort Sheridan Advisors's ten largest holdings make up 48% of its $297M portfolio in Q3 2022.
  • Fort Sheridan Advisors opened 9 new positions and closed 10 in Q3 2022.
  • Fort Sheridan Advisors's portfolio value fell 3.6% quarter-over-quarter to $297M.

Based on Fort Sheridan Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.